Skip to content
Solved
SearchBrowse
Sign in

Contents

Official guidance
Company Taxation Manual

CTM20500 · ACT: tax credit & FA93

  • CTM20505 · Background
  • CTM20510 · Summary of main changes
  • CTM20515 · Reason for the changes
  • CTM20520 · Effects of main changes
  • CTM20525 · Rate at which ACT is payable
  • CTM20530 · Rate of tax credit
  • CTM20535 · Claims under ICTA88/S242 & S243
  • CTM20540 · Franked investment income: as upper limit
  • CTM20545 · Franked investment income: used to frank payments
  • CTM20550 · Franked investment income: small companies relief and mutual concerns
  • CTM20555 · Stock dividends: IT treated as paid
  • CTM20560 · Loan released or written off
  • CTM20565 · Non-qualifying distributions etc
  • CTM20570 · FID
  1. ACT: tax credit & FA93: contents
  2. ACT: tax credit & FA93: claims under ICTA88/S242 & S243

CTM20535 | ACT: tax credit & FA93: claims under ICTA88/S242 & S243

From HM Revenue & Customs · Company Taxation Manual

A company might have made a Section 242 claim on surplus franked investment income using franked investment income of 1993-94. Because of the restriction on the amount oftax credit paid for 1993-94 the surplus franked investment income so used was calculated as if the tax credit comprised in it was calculated at a rate of 1/4, (FA93/S78 (8)).

For identification of the surplus franked investment income, see CTM16215.

Franked investment income used in a Section 242 claim was deducted from surplus franked investment income carried forward for the purposes of ICTA88/S241 and ICTA88/SCH13, (ICTA88/S242 (1)(b)). Because for 1993-94 franked investment income was generally calculated with a tax credit at 9/31, but for Section 242 purposes was calculated with a tax credit at 1/4, this would have left an amount remaining which represented the difference between the tax credit rates. To overcome this a further reduction was made from the surplus franked investment income carried forward to represent this difference, (FA93/S78 (9)).

PreviousNext
PrivacyTerms